Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in COVID-19 Pneumonia (CORTIVID)
NCT04438980Phase 3Completed
- Sponsor
- Fundación Miguel Servet
- Start
- May 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of methylprednisolone injection in COVID-19 pneumonia, sponsored by Fundación Miguel Servet. Primary endpoint: Proportion of patients developing treatment failure at 14 days. Started May 2020; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04438980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438980.